Successful management of predicted severe ovarian hyperstimulation syndrome with gonadotropin-releasing hormone agonist.
Wu
T C
TC
Department of Obstetrics and Gynecology School of Medicine, University of California, Los Angeles 90024.
Gelety
T J
TJ
Jih
M H
MH
Fournet
N
N
Buyalos
R
R
D000328:Adult; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D016471:Ovarian Hyperstimulation Syndrome / Q000517:prevention & control*; D010062:Ovulation Induction / Q000009:adverse effects*; D017329:Triptorelin Pamoate / Q000031:analogs & derivatives*
D003692:Delayed-Action Preparations; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; C019176:Tryptal; D016729:Leuprolide